The Swiss Medtech company Symetis and Boston Scientific have reached a definitive purchase agreement whereby Boston Scientific will acquire Symetis for $435 million in an all cash, up-front payment.
April 03, 2017 at 01:09PM
http://ift.tt/2nNuIhe
from Startupticker
http://ift.tt/2nNuIhe
No comments:
Post a Comment